Williams' research has focused on the formulation development, optimization, and delivery of small organic compounds, peptides, and proteins by a
variety of technologies, including depot drug delivery, oral drug delivery and pulmonary/nasal drug delivery.
Work in Dr. Croyle's lab focuses on the development of novel methods for rapid immunization against dangerous pathogens like Ebola. Additional projects focus
on the long-term physiological effects of virus infection with respect to the immune response and drug metabolism. As these progress toward clinical
application, our work also addresses the need for novel formulations to enhance both the physical stability and potency of virus-based preparations as well as
methods by which to deliver them through the mucosal route.
Zhengrong Cui's research focuses on rational drug and vaccine delivery including nanoparticles for vaccine and anti-cancer drug delivery, non-invasive immunization onto the skin, and cancer chemo-immunotherapy.
Doluisio is the Hoechst-Roussel Centennial Professor Emeritus of Pharmacy . He has written more than 90 papers on bioequivalency and drug absorption, biopharmaceutics, pharmacokinetics, physical pharmacy, pharmacy education and various pharmacy issues for national and international journals, textbooks and conferences.
Work in Dr. Ghosh's lab focuses on biologically-inspired, rational design of biomolecules (i.e. antibodies and peptides) and nanoscale materials for cancer
diagnostics and therapeutics. One area of emphasis is the development of novel fluorescence nanoparticles to improve early detection, guided surgical
interventions, and monitoring of therapy regimens. Another long-term goal of the lab is to engineer particle systems able to overcome the complex transport
barriers presented by solid tumors for improved delivery and uptake of imaging agents and therapeutics.
Our current research is focused on thermal processing technologies,
including hot-melt extrusion and KinetiSol® processing, to increase the dissolution rate and bioavailability of poorly water soluble drugs.
Peppas, Nicholas A., Sc.D.
Fletcher Stuckey Pratt Chair in Engineering
Cockrell Family Chair for
Departmental Leadership #1
Professor of Pharmaceutics/Joint
BME 3.110 and CPE 3.466
Work in Dr Peppas' laboratory focuses on the use of intelligent biopolymers for drug and protein delivery under conditions of external physiological triggering mechanisms. In addition, his group is developing novel transmucosal and oral delivery systems for insulin, interferon-beta and calcitonin and is studying the potential of developing novel transmucosal systems for siRNA delivery.
Peters, Jay, MD, FCCP
Adjunct Professor of Pharmaceutics
Chief of Pulmonary Diseases and
Critical Care Medicine
University of Texas Health Science Center San Antonio
We are involved in basic and clinical research in the evaluation of pulmonary infection, chronic obstructive lung disease, asthma, lung transplantation and pulmonary fibrosis.
Work in Dr. Smyth's
lab focuses on the development of novel methods for drug delivery to the airways in health and disease. For example, his group investigates unique microparticle aerosols for
controlled release, transformative inhaler and device designs, nanoparticle enhancers for drug transport, inhaled vaccines, and other areas of respiratory drug delivery.
Translation of these technologies to the clinic is the long-term goal of the lab and is supported by developing a mechanistic understanding of the complex physical and
The primary mission of Stavchansky's laboratories is to apply the principles of
biopharmaceutics, pharmacokinetics, and drug metabolism to evaluate and design drug delivery systems to ensure the
safety and efficacy of drug products.
The Drug Dynamics Institute is a multi-disciplinary
research center where scientists, educators, businesses and regulatory agencies collaborate
in finding solutions to a wide range of biomedical, pharmaceutical and public health issues.
Watts works with development-focused pharmaceutical researchers in academia and industry in advancing drug products through the preclinical stage.
Our lab focuses on designing novel manufacturing processes and formulation compositions to prepare amorphous dispersions of BCS classes II and IV
compounds in order to improve these compounds' pharmacokinetic performance. Our lab is developing analytical methodologies to study short and
medium range order of amorphous solid dispersions. Our lab is also evaluating twin screw extrusion in a wide range of pharmaceutical manufacturing
processes. Other research interests include abuse deterrence and taste masking technologies.
Link to our directories page
for additional directory information.
Last Reviewed: February 17, 2014